We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$5.04B
AUM Growth
+$540M
Cap. Flow
+$108M
Cap. Flow %
2.14%
Top 10 Hldgs %
47.44%
Holding
76
New
17
Increased
18
Reduced
10
Closed
14

Top Sells

Rank Stock Value
1
SNAP icon
Snap
SNAP
+$161M
2
IBM icon
IBM
IBM
+$110M
3
GE icon
GE Aerospace
GE
+$85.6M
4
DXCM icon
DexCom
DXCM
+$78.4M
5
MU icon
Micron Technology
MU
+$70.3M

Sector Composition

Rank Sector Weight
1 Technology 27.4%
2 Healthcare 19.77%
3 Materials 14.77%
4 Energy 11.22%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
51
Cue Biopharma
CUE
$118M
$4.54M 0.09%
80,082
LAB icon
52
Standard BioTools
LAB
$342M
$4.38M 0.09%
+1,615,000
New +$3.9M
VIST icon
53
Vista Energy
VIST
$7.35B
$3.93M 0.08%
+95,000
New +$3.3M
VST icon
54
Vistra
VST
$48.2B
$2.36M 0.05%
+33,900
New +$1.68M
CEG icon
55
Constellation Energy
CEG
$92.1B
$2.29M 0.05%
+12,400
New +$1.76M
NRG icon
56
NRG Energy
NRG
$26.2B
$2.03M 0.04%
+30,000
New +$1.68M
CYCN icon
57
Cyclerion Therapeutics
CYCN
$15.2M
$1.15M 0.02%
357,880
PLG
58
Platinum Group Metals
PLG
$160M
$1.05M 0.02%
900,000
NEXI
59
DELISTED
NexImmune, Inc. Common Stock
NEXI
$208K ﹤0.01%
36,999
AUROW
60
Aurora Innovation Warrant
AUROW
$317M
$118K ﹤0.01%
437,500
BLUA.WS
61
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$13.1K ﹤0.01%
200,000
HIPO.WS
62
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$7.35K ﹤0.01%
350,000
ATEC icon
63
Alphatec Holdings
ATEC
$1.48B
-2,155,000
Closed -$32.6M
BBD icon
64
Banco Bradesco
BBD
$37.4B
-5,824,000
Closed -$20.4M
CLS icon
65
Celestica
CLS
$37.8B
-966,000
Closed -$28.3M
COIN icon
66
Coinbase
COIN
$42.2B
-235,300
Closed -$40.9M
DXCM icon
67
DexCom
DXCM
$29B
-632,000
Closed -$78.4M
ENPH icon
68
Enphase Energy
ENPH
$4.62B
-28,200
Closed -$3.73M
IBM icon
69
IBM
IBM
$213B
-670,970
Closed -$110M
INSP icon
70
Inspire Medical Systems
INSP
$1.47B
-294,000
Closed -$59.8M
ITUB icon
71
Itaú Unibanco
ITUB
$89.8B
-3,903,185
Closed -$23.9M
PBF icon
72
PBF Energy
PBF
$7.49B
-735,708
Closed -$32.3M
PRM icon
73
Perimeter Solutions
PRM
$5.66B
-3,024,000
Closed -$13.9M
RIVN icon
74
Rivian
RIVN
$23.6B
-231,000
Closed -$5.42M
ROIV icon
75
Roivant Sciences
ROIV
$23.6B
-2,460,000
Closed -$27.6M

Similar funds

Slate Path Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Slate Path Capital held 76 positions worth $5.04B, up 12% from $4.51B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Slate Path Capital's Q1 2024 filing shows 17 new, 18 increased, 10 reduced and 14 closed positions. Its largest new stake was Sea Limited: 2,895,200 shares worth $156M. The largest sale was Snap, an estimated $161M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Materials.

  • Slate Path Capital's largest Q1 2024 buy was Sea Limited: 2,895,200 shares worth $156M.
  • Slate Path Capital added most to Arrowhead Research in Q1 2024, an estimated $89.9M increase.
  • Slate Path Capital's biggest Q1 2024 reduction was GE Aerospace, cutting an estimated $85.6M.
  • Slate Path Capital fully exited Snap in Q1 2024, selling an estimated $161M.
  • Slate Path Capital's ten largest holdings make up 47% of its $5.04B portfolio in Q1 2024.
  • Slate Path Capital opened 17 new positions and closed 14 in Q1 2024.
  • Slate Path Capital's portfolio value rose 12% quarter-over-quarter to $5.04B.

Based on Slate Path Capital's 13F filing for Q1 2024, filed 15 May 2024.